Organogenesis (NasdaqCM:ORGO) Q3 2026 Earnings call November 05, 2026 05:00 PM ET Company ParticipantsGary Gillheeney Sr. - President, CEO, and Chair of the BoardDave Francisco - CFOConference Call ParticipantsRyan Zimmerman - AnalystRavi Misra - AnalystOperatorWelcome, ladies and gentlemen, to the third quarter 2026 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that th ...